Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
The history of FEIBA: a lifetime of success in the treatment of haemophilia complicated by an inhibitor
Haemophilia, 11/17/06
Négrier.C, et al. - The development of alloantibodies that inhibit the function of factor VIII (FVIII) or factor IX (FIX) is the most serious complication associated with the treatment of haemophilia. Bleeding events in patients with high-titre inhibitors generally cannot be managed with factor replacement therapy and require alternative strategies for haemostatic support
Related Articles
Malignancy in patients with haemophilia: a review of the literature
Haemophilia, 11/16/09
Relevance Score: 89%%
Co-morbidities and quality of life in elderly persons with haemophilia
British Journal of Haematology, 12/12/09
Relevance Score: 87%%
Major orthopaedic surgeries for haemophilia with inhibitors using rFVIIa
Haemophilia, 11/25/09
Relevance Score: 85%%
The optimal mode of delivery for the haemophilia carrier expecting an affected infant is vaginal delivery
Haemophilia, 11/25/09
Relevance Score: 85%%
Upper gastrointestinal bleeding in children with haemophilia: a clinical significance of Helicobacter pylori infection
Haemophilia, 11/09/09
Relevance Score: 85%%
Today in Coagulation/Bleeding Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)
Journal of Thrombosis and Haemostasis, 12/20/09
The mitogen-activated protein kinase signaling pathways: role in megakaryocyte differentiation
Journal of Thrombosis and Haemostasis, 12/20/09
Thrombotic thrombocytopenic purpura at the Johns Hopkins Hospital from 1992 to 2008: clinical outcomes and risk factors for relapse
Transfusion, 12/19/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase
Journal of Clinical Oncology, 12/20/09
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Journal of Clinical Oncology, 12/20/09
Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia
Journal of Clinical Oncology, 12/20/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


